Loading
Total declarations
Companies
▲ Purchases (18 ops.)
▼ Sales (0 ops.)
Latest filing published 13 May 2016 for AGENUS INC, €80k.
Insider track record
Disclosed buys
18
Disclosed sells
0
Signal history
Closed purchases
Market purchases
18
Positive at T+90
50%
Median T+90
+16.2%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +57.5%Entry US$89.50 · Close at T+365 US$140.92
- +39.7%Entry US$11,900.00 · Close at T+365 US$16,625.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Charles Evan Ballantyne: trading record in brief
Charles Evan Ballantyne has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Clinical Data Inc, Agenus Inc and Theriva Biologics, Inc. The record holds 24 filings, for trades running from 21 August 2006 to 26 April 2016.
The open-market record is one-sided, with 18 purchases worth €123k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 3 share grants.
In size, the median ticket on the buying side is €3,002.
The latest filing, published on 13 May 2016, reports a share grant of €80k in Agenus Inc. The last purchase on record was published on 29 September 2015, which is 4,042 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Charles Evan Ballantyne
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations24 total
21,902 shares@ US$4.1537.9% of flowCommon StockSEC:0001288123-16-000071:0
7,107 shares@ US$4.1512.3% of flowCommon StockSEC:0001288123-16-000071:1
21,683 shares@ US$4.1537.6% of flowCommon StockSEC:0001288123-16-000063:0
7,035 shares@ US$4.1512.2% of flowCommon StockSEC:0001288123-16-000063:1
10,000 shares@ US$5.05Commmon StockSEC:0001288123-15-000039:0
Canonical exit: 24 Dec 2015 (T+90)
10,000 shares@ US$1.35Common StockSEC:0001144204-14-033539:0
Canonical exit: 20 Aug 2014 (T+90)
5,600 shares@ US$30.00Common StockSEC:0001209191-11-022907:0
200 shares@ US$21.28Common StockSEC:0001209191-07-069864:0
Canonical exit: 13 Mar 2008 (T+90)
100 shares@ US$21.37Common StockSEC:0001209191-07-069864:1
Canonical exit: 13 Mar 2008 (T+90)
100 shares@ US$21.43Common StockSEC:0001209191-07-069864:2
Canonical exit: 13 Mar 2008 (T+90)
100 shares@ US$21.76Common StockSEC:0001209191-07-069864:3
Canonical exit: 13 Mar 2008 (T+90)
100 shares@ US$21.77Common StockSEC:0001209191-07-069864:4
Canonical exit: 13 Mar 2008 (T+90)
50 shares@ US$21.80Common StockSEC:0001209191-07-069864:5
Canonical exit: 13 Mar 2008 (T+90)
600 shares@ US$21.63Common StockSEC:0001209191-07-069864:6
Canonical exit: 13 Mar 2008 (T+90)
200 shares@ US$21.33Common StockSEC:0001209191-07-069864:7
Canonical exit: 13 Mar 2008 (T+90)
200 shares@ US$21.34Common StockSEC:0001209191-07-069864:8
Canonical exit: 13 Mar 2008 (T+90)
200 shares@ US$22.00Common StockSEC:0001209191-07-069902:0
Canonical exit: 13 Mar 2008 (T+90)
100 shares@ US$26.28Common StockSEC:0001209191-07-052373:0
Canonical exit: 5 Dec 2007 (T+90)
200 shares@ US$26.38Common StockSEC:0001209191-07-052373:1
Canonical exit: 5 Dec 2007 (T+90)
400 shares@ US$26.58Common StockSEC:0001209191-07-052373:2
Canonical exit: 5 Dec 2007 (T+90)
800 shares@ US$26.70Common StockSEC:0001209191-07-052373:3
Canonical exit: 5 Dec 2007 (T+90)
600 shares@ US$16.79Common StockSEC:0001209191-06-064032:0
Canonical exit: 11 Mar 2007 (T+90)
400 shares@ US$12.46Common StockSEC:0001209191-06-047887:0
Canonical exit: 19 Nov 2006 (T+90)
400 shares@ US$12.46Common StockSEC:0001209191-06-046974:0
24 of 24 declarations
